Serna, N.; Carratalá, J.V.; Conchillo-Solé, O.; MartÃnez-Torró, C.; Unzueta, U.; Mangues, R.; Ferrer-Miralles, N.; Daura, X.; Vázquez, E.; Villaverde, A.
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4. Pharmaceutics 2021, 13, 1922.
https://doi.org/10.3390/pharmaceutics13111922
AMA Style
Serna N, Carratalá JV, Conchillo-Solé O, MartÃnez-Torró C, Unzueta U, Mangues R, Ferrer-Miralles N, Daura X, Vázquez E, Villaverde A.
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4. Pharmaceutics. 2021; 13(11):1922.
https://doi.org/10.3390/pharmaceutics13111922
Chicago/Turabian Style
Serna, Naroa, José Vicente Carratalá, Oscar Conchillo-Solé, Carlos MartÃnez-Torró, Ugutz Unzueta, Ramón Mangues, Neus Ferrer-Miralles, Xavier Daura, Esther Vázquez, and Antonio Villaverde.
2021. "Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4" Pharmaceutics 13, no. 11: 1922.
https://doi.org/10.3390/pharmaceutics13111922
APA Style
Serna, N., Carratalá, J. V., Conchillo-Solé, O., MartÃnez-Torró, C., Unzueta, U., Mangues, R., Ferrer-Miralles, N., Daura, X., Vázquez, E., & Villaverde, A.
(2021). Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4. Pharmaceutics, 13(11), 1922.
https://doi.org/10.3390/pharmaceutics13111922